📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! Tell us what works, what doesn't, and how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community. Please send your feedback to gateway@ukri.org by 11 August 2025.

Age-Related Seroprevalence of Antibodies Against AAV-LK03 in a UK Population Cohort. (2019)

First Author: Perocheau DP

Attributed to: Phase I/II clinical trial evaluating AAV-mediated gene therapy for a severe paediatric metabolic liver disease: Ornithine Transcarbamylase deficiency funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1089/hum.2018.098

PubMed Identifier: 30027761

Publication URI: http://europepmc.org/abstract/MED/30027761

Type: Journal Article/Review

Volume: 30

Parent Publication: Human gene therapy

Issue: 1

ISSN: 1043-0342